XML 22 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities      
Net income (loss) $ (238,340) $ (99,364) $ 81,945
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Loss (gain) on debt modification and extinguishment, net 1,357 1,932 (10,896)
Depreciation and amortization, net 353,890 344,910 365,429
Asset impairment 29,618 23,003 107,308
Equity in (earnings) loss of unconsolidated ventures 10,782 (10,394) 2,107
Distributions from unconsolidated ventures from cumulative share of net earnings 561 6,191 766
Amortization of entrance fees (2,307) (1,758) (2,122)
Proceeds from deferred entrance fee revenue 4,222 3,562 734
Deferred income tax (benefit) provision (1,324) (9,837) (5,840)
Operating lease expense adjustment (34,896) (23,280) (136,276)
Change in fair value of derivatives (7,659) 152 225
Loss (gain) on sale of assets, net (74,445) (288,835) (374,532)
Loss (gain) on facility operating lease termination, net 0 (2,003) (2,303)
Non-cash stock-based compensation expense 14,466 16,270 20,747
Property and casualty insurance income (11,379) (4,689) (2,777)
Changes in operating assets and liabilities:      
Accounts receivable, net (4,624) 502 24,277
Prepaid expenses and other assets, net (21,240) (15,483) 24,707
Trade accounts payable and accrued expenses (27,185) (54,032) 27,294
Refundable fees and deferred revenue (1,934) (10,066) 62,614
Operating lease assets and liabilities for lessor capital expenditure reimbursements 13,718 30,965 22,242
Operating lease assets and liabilities for lease termination 0 (2,380) 0
Net cash provided by (used in) operating activities 3,281 (94,634) 205,649
Cash Flows from Investing Activities      
Change in lease security deposits and lease acquisition deposits, net 355 (100) 3,569
Purchase of marketable securities (263,669) (362,257) (378,269)
Sale and maturities of marketable securities 398,752 352,988 275,000
Capital expenditures, net of related payables (196,924) (176,657) (185,871)
Acquisition of assets (6,004) 0 (472,193)
Investment in unconsolidated ventures (218) (5,436) (4,082)
Distributions received from unconsolidated ventures 966 37,113 0
Proceeds from sale of assets, net 4,653 334,006 331,316
Proceeds from notes receivable 0 1,800 5,419
Other (5,340) 0 0
Net cash provided by (used in) investing activities (67,429) 181,457 (425,111)
Cash Flows from Financing Activities      
Proceeds from debt 254,259 352,962 963,099
Repayment of debt and financing lease obligations (281,185) (441,571) (538,859)
Proceeds from line of credit 0 0 166,381
Repayment of line of credit 0 0 (166,381)
Proceeds from issuance of tangible equity units 139,438 0 0
Purchase of treasury stock, net of related payables 0 0 (18,123)
Purchase of capped call transactions 0 (15,916) 0
Payment of financing costs, net of related payables (7,077) (3,904) (19,649)
Payments of employee taxes for withheld shares (4,293) (4,820) (4,037)
Other (760) (408) 482
Net cash provided by (used in) financing activities 100,382 (113,657) 382,913
Net increase (decrease) in cash, cash equivalents, and restricted cash 36,234 (26,834) 163,451
Cash, cash equivalents, and restricted cash at beginning of period 438,314 465,148 301,697
Cash, cash equivalents, and restricted cash at end of period $ 474,548 $ 438,314 $ 465,148